Skip to main content
CIROMED - Home
Find a Doctor
DE|EN
For Physicians

Frequently Asked Questions

Reliable information about dry AMD, photobiomodulation, and the MACULIGHT clinical study.

Questions and Answers

Photobiomodulation (PBM) uses specific wavelengths of light to stimulate cellular processes. Its potential use for dry age-related macular degeneration is being investigated in clinical studies.

Do you have another question?

Send us a message or contact the Ciromed team directly.

Email

info@ciromed.de

Phone

+49 (0)30 223995 2920

Address

Ciromed GmbH
Kölner Straße 31
51379 Leverkusen

CIROMED
Federal Ministry for Research, Technology and Space

The MACULIGHT therapy clinical trial is funded by the BMFTR.

UNDERSTANDING AMD

  • What is AMD?
  • Dry vs. Wet AMD
  • Recognizing Symptoms
  • Causes & Risk Factors

TREATMENT

  • Treatment Options
  • Photobiomodulation
  • MACULIGHT Therapy
  • News
  • Find a Doctor

LEGAL

  • Legal Notice
  • Privacy Policy

COMPANY

  • About Us
  • Contact
  • FAQ
  • Sitemap

Note: MACULIGHT® is a medical device under clinical investigation. The information presented on this website is for general educational purposes only and does not replace medical advice, diagnosis, or treatment. All efficacy claims refer to published study results on photobiomodulation and do not guarantee individual treatment outcomes. Please consult your ophthalmologist before making changes to your treatment plan.

© 2026 Ciromed GmbH. All rights reserved.